Showing results (31-40 of 243) with videos related to
Sort By:
Pageof 25
Cancer Research and Treatment|June 19, 2018
NFATC3-PLA2G15 Fusion Transcript Identified by RNA Sequencing Promotes Tumor Invasion and Proliferation in Colorectal Cancer Cell LinesJee-Eun Jang, Hwang-Phill Kim, Sae-Won Han, et al.The British Journal of Radiology|March 14, 2019
Results of re-irradiation for pelvic recurrence in anorectal cancer patientsYounghee Park, Kyubo Kim, Hae Jin Park, et al.Scientific Reports|March 11, 2020
Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective studyTaeryool Koo, Kyubo Kim, Hae Jin Park, et al.Scientific Reports|May 3, 2017
Asymmetrical barcode adapter-assisted recovery of duplicate reads and error correction strategy to detect rare mutations in circulating tumor DNAJinwoo Ahn, Byungjin Hwang, Ha Young Kim, et al.Molecular Oncology|June 14, 2018
Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cellsSeul-Ki Cheon, Hwang-Phill Kim, Ye-Lim Park, et al.Plos One|October 6, 2015
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass IndexYounak Choi, Do-Youn Oh, Tae-Yong Kim, et al.Journal of Pain and Symptom Management|December 11, 2013
The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapyYounak Choi, Tae-Yong Kim, Kyung-hun Lee, et al.International Journal of Clinical Oncology|August 4, 2018
Novel graded prognostic assessment for colorectal cancer patients with brain metastasesByoung Hyuck Kim, Hae Jin Park, Kyubo Kim, et al.Cancer Research and Treatment|March 18, 2015
The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing ChemotherapyYounak Choi, Tae-Yong Kim, Do-Youn Oh, et al.Cancer Chemotherapy and Pharmacology|February 18, 2011
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage settingKyu-Hyoung Lim, Tae-Yong Kim, Kyung-Hun Lee, et al.Pageof 25